JENNA NASSAR: Open Payments
NPI 1396355095 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,714 in 55 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,714
Food & beverage: $1,589Travel & lodging: $1,126
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 8 | $1,723 |
| SK Life Science, Inc. | 3 | $171 |
| Neurocrine BioSciences, Inc. | 6 | $118 |
| Tanabe Pharma America, Inc. | 6 | $113 |
| ABBVIE INC. | 5 | $111 |
| Alexion Pharmaceuticals, Inc. | 5 | $91 |
| Lundbeck LLC | 5 | $85 |
| Averitas Pharma Inc. | 4 | $76 |
| UCB, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
Products named: VNS Therapy, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, XCOPRI, INGREZZA, BOTOX, Radicava, ULTOMIRIS, VYEPTI.
Industry payments across NY — which companies pay providers there.
